iCAP-BI103-KanR
(Plasmid
#203537)
-
PurposeRepCap for AAV production
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 203537 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonekiCAP
-
Vector typeMammalian Expression, AAV
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameAAV-BI103 Cap
-
SpeciesSynthetic
Cloning Information
- Cloning method Unknown
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
iCAP-BI103-KanR was a gift from Ben Deverman (Addgene plasmid # 203537 ; http://n2t.net/addgene:203537 ; RRID:Addgene_203537) -
For your References section:
A marmoset brain cell census reveals regional specialization of cellular identities. Krienen FM, Levandowski KM, Zaniewski H, Del Rosario RCH, Schroeder ME, Goldman M, Wienisch M, Lutservitz A, Beja-Glasser VF, Chen C, Zhang Q, Chan KY, Li KX, Sharma J, McCormack D, Shin TW, Harrahill A, Nyase E, Mudhar G, Mauermann A, Wysoker A, Nemesh J, Kashin S, Vergara J, Chelini G, Dimidschstein J, Berretta S, Deverman BE, Boyden E, McCarroll SA, Feng G. Sci Adv. 2023 Oct 13;9(41):eadk3986. doi: 10.1126/sciadv.adk3986. Epub 2023 Oct 12. 10.1126/sciadv.adk3986 PubMed 37824615